(Total Views: 267)
Posted On: 09/18/2023 10:00:49 AM
Post# of 68

$BCRX News Article - INESSS Recommends Public Reimbursement for BioCryst's ORLADEYO (berotralstat) for the Prevention of Attacks for Hereditary Angioedema Patients in Qu bec https://marketwirenews.com/news-releases/ines...40066.html


My Twitter: WhyteStocks